Vertex Pharmaceuticals Q3 2026 Earnings Preview
- Vertex Pharmaceuticals (VRTX) is scheduled to announce Q3 earnings results on Monday, November 2, after market close.
- The consensus EPS estimate is $4.75 (-1.0% Y/Y), and the consensus revenue estimate is $3.43B (+11.4% Y/Y).
- Over the last 2 years, VRTX
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.